Annovis Bio, Inc. ANVS
Set alert
1.12 USD +0.03 +3.24%
As of Nov 3, 2:09 PM ET
1.06 Day range 1.15
0.93 52-week range 5.50
- YTD
- -67.77%
- 1 year
- -44.80%
- Open
- 1.07
- Prev close
- 1.08
- Mkt cap
- 47.59M
- Vol
- 474.23K
- Avg vol
- 942.79K
- EPS
- -1.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.06
- High
- 1.15
- Forward P/E
- -2.77
- Beta
- 0.00
- Short ratio
- 6.21
- Inst. own
- 8.83%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 7.29
- 200-d avg
- 8.47
- 1y target
- 34.80
5D chart
Signals (104)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 1:45 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 1:45 PM | 1 day ago |
| RSI: Oversold | Nov 2, 1:25 PM | 1 day ago |
| SMA: Bearish | Nov 2, 12:40 PM | 1 day ago |
| SMA: Bullish | Nov 2, 12:35 PM | 1 day ago |
| SMA: Bearish | Nov 2, 10:55 AM | 1 day ago |
| MACD: Sell Signal | Nov 2, 10:40 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:30 AM | 1 day ago |
| MACD: Buy Signal | Nov 2, 9:35 AM | 1 day ago |
| RSI: Overbought | Nov 2, 9:35 AM | 1 day ago |
| SMA: Bearish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 3:30 PM | 3 days ago |
| RSI: Overbought | Oct 30, 3:10 PM | 4 days ago |
| RSI: Overbought | Oct 30, 2:25 PM | 4 days ago |
| MACD: Buy Signal | Oct 30, 2:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 30, 2:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 30, 2:00 PM | 4 days ago |
| RSI: Overbought | Oct 30, 2:00 PM | 4 days ago |
Newest 20 of 104.
Financial health
Altman Z-Score
-18.08 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -2.5×
FY 2017 5y median -3.0× FY 2025
P/S 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 4.2×
FY 2017 5y median 3.9× FY 2025
P/FCF -2.8×
FY 2017 5y median -4.2× FY 2025
EV/EBITDA -1.8×
FY 2017 5y median -2.9× FY 2025
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -36.0%
FY 2017 5y median -23.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -171.2%
FY 2017 5y median -89.4% FY 2025
ROIC -170.2%
FY 2017 5y median -170.2% FY 2025
ROA -136.9%
FY 2017 5y median -136.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -11.2%
FY 2017 FY 2025
EPS (diluted) 39.4%
FY 2017 FY 2025
Free Cash Flow -17.0%
FY 2017 FY 2025
Financial Health
Current Ratio 5.8×
FY 2017 5y median 4.7× FY 2025
Quick Ratio 5.8×
FY 2017 5y median 4.7× FY 2025
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2017 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
